Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who are enrolled in the French Social Security scheme
- People who have given their informed consent to participate, confirmed in writing
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who are under judicial protection measures
- People who are under guardianship or curatorship
- People who have another neurodegenerative disease (a condition affecting the brain or nervous system other than the one being studied)
- People who use eye drops or any treatment that could affect tear production
- People who have worn contact lenses occasionally or regularly in the last 3 months
- People who have had eye surgery within the last 3 months
- People who have an eye condition other than refractive errors (such as needing glasses), eye movement disorders, or amblyopia (lazy eye)
- People who have a general health condition, other than the condition being studied, that affects the eyes
- People who are unable to have their tears collected for the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Victoire LEROY, MD, CHRU de Tours
Phone: 0247477693
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of total Tau proteins in basal tears of patients with AD vs healthy volunteers; Concentration of phosphorylated Tau proteins in basal tears of patients with AD vs healthy volunteers; Concentration of Amyloid β 1-40 proteins in basal tears of patients with AD vs healthy volunteers; Concentration of Amyloid β 1-42 in basal tears of patients with AD vs healthy volunteers; Lipids in basal tears of patients with AD vs healthy volunteers; Metabolites in basal tears of patients with AD vs healthy volunteers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.